Sonnest, Inc. is pre-clinical healthcare company developing Electrast™, an ultrasound imaging drug that circulates through the body in the inactive state (dark on ultrasound) and is selectively activated (turned on) in the myocardium. With Electrast™ doctors will be able to evaluate perfusion of the heart quickly and cost-effectively at the point of care without exposure to ionizing radiation or toxic dies. The technology was developed by a talented team of cardiologists and chemical engineers at Drexel University with grant funding from the Coulter-Drexel Program and the inventors partnered with a team of successful serial healthcare entrepreneurs who have worked together for over 15 years across multiple companies to form Sonnest.
Company Details
- Employees
- 3
- Address
- 323 West Camden Street,
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.sonnest.com
- Keywords
- Pain Labs.
- HQ
- Baltimore, Md
Sonnest, Inc. Questions
Sonnest, Inc.'s website is http://www.sonnest.com
Sonnest, Inc.'s LinkedIn profile is https://www.linkedin.com/company/sonnest
Sonnest, Inc. has
3 employees.
View email and phone details for 3
employees at Sonnest, Inc..
Sonnest, Inc.'s industry is
Medical Equipment Manufacturing
Sonnest, Inc.'s top competitors are
Stanford Mussallem Center For Biodesign,
Whimsifull,
Focus Academy, Llc,
Regeltec, Inc,
Coaptech,
Singular Health Group Ltd,
Pain Labs,
Discerene Group Lp,
Truetraction Ai,
Promedics Ag.
Sonnest, Inc.'s categories are Medical Equipment Manufacturing
